Belloum, Y.; Janning, M.; Mohme, M.; Simon, R.; Kropidlowski, J.; Sartori, A.; Irwin, D.; Westphal, M.; Lamszus, K.; Loges, S.;
et al. Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay. Cells 2020, 9, 2337.
https://doi.org/10.3390/cells9112337
AMA Style
Belloum Y, Janning M, Mohme M, Simon R, Kropidlowski J, Sartori A, Irwin D, Westphal M, Lamszus K, Loges S,
et al. Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay. Cells. 2020; 9(11):2337.
https://doi.org/10.3390/cells9112337
Chicago/Turabian Style
Belloum, Yassine, Melanie Janning, Malte Mohme, Ronald Simon, Jolanthe Kropidlowski, Alexander Sartori, Darryl Irwin, Manfred Westphal, Katrin Lamszus, Sonja Loges,
and et al. 2020. "Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay" Cells 9, no. 11: 2337.
https://doi.org/10.3390/cells9112337
APA Style
Belloum, Y., Janning, M., Mohme, M., Simon, R., Kropidlowski, J., Sartori, A., Irwin, D., Westphal, M., Lamszus, K., Loges, S., Riethdorf, S., Pantel, K., & Wikman, H.
(2020). Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay. Cells, 9(11), 2337.
https://doi.org/10.3390/cells9112337